The insulin-like growth factor 1 receptor in cancer: Old focus, new future

被引:144
作者
Hartog, Hermien
Wesseling, Jelle
Boezen, H. Marike
van der Graaf, Winette T. A.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Groningen, Med Ctr, Dept Oncol, Groningen, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands
[4] Univ Groningen, Med Ctr, Dept Epidemiol, Groningen, Netherlands
关键词
insulin-like growth factor 1 receptor; insulin receptor; hybrid receptor; tyrosine kinase inhibitors; targeted therapy; growth factor receptor; antibody; cancer;
D O I
10.1016/j.ejca.2007.05.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The importance of insulin-like growth factor I receptor (IGF-1R) signalling in malignant behaviour of tumour cells is well established. Currently, development of drugs targeting the IGF-1R as anticancer treatment is emerging. Several IGF-1R targeting strategies are being investigated in phases 1 and 11 clinical trials. interactions of IGF-1R with insulin receptor, however, might complicate efficiency and tolerability of such drugs. This review describes mechanisms, recent developments and potential limitations of IGF-1R antibodies and tyrosine kinase inhibitors. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1895 / 1904
页数:10
相关论文
共 106 条
[61]   Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells [J].
Nahta, R ;
Yuan, LYH ;
Zhang, B ;
Kobayashi, R ;
Esteva, FJ .
CANCER RESEARCH, 2005, 65 (23) :11118-11128
[62]   Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer [J].
Nahta, Rita ;
Yu, Dihua ;
Hung, Mien-Chie ;
Hortobagyi, Gabriel N. ;
Esteva, Francisco J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05) :269-280
[63]   Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers [J].
Nakamura, M ;
Miyamoto, S ;
Maeda, H ;
Zhang, SC ;
Sangai, T ;
Ishii, G ;
Hasebe, T ;
Endoh, Y ;
Saito, N ;
Asaka, M ;
Ochiai, A .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8434-8441
[64]   A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis [J].
Niedernhofer, Laura J. ;
Garinis, George A. ;
Raams, Anja ;
Lalai, Astrid S. ;
Robinson, Andria Rasile ;
Appeldoorn, Esther ;
Odijk, Hanny ;
Oostendorp, Roos ;
Ahmad, Anwaar ;
Van Leeuwen, Wibeke ;
Theil, Arjan F. ;
Vermeulen, Wim ;
van der Horst, Gijsbertus T. J. ;
Meinecke, Peter ;
Kleijer, Wim J. ;
Vijg, Jan ;
Jaspers, Nicolaas G. J. ;
Hoeijmakers, Jan H. J. .
NATURE, 2006, 444 (7122) :1038-1043
[65]   Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: Potential for intervention with 17-allylamino geldanamycin [J].
Nielsen, TO ;
Andrews, HN ;
Cheang, M ;
Kucab, JE ;
Hsu, FD ;
Ragaz, J ;
Gilks, CB ;
Makretsov, N ;
Bajdik, CD ;
Brookes, C ;
Neckers, LM ;
Evdokimova, V ;
Huntsman, DG ;
Dunn, SE .
CANCER RESEARCH, 2004, 64 (01) :286-291
[66]  
Oesterreich S, 2001, CANCER RES, V61, P5771
[67]  
Pandini G, 1999, CLIN CANCER RES, V5, P1935
[68]   Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors [J].
Pandini, Giuseppe ;
Wurch, Thierry ;
Akla, Barbara ;
Corvaia, Nathalie ;
Belfiore, Antonino ;
Goetsch, Liliane .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (08) :1318-1327
[69]  
PAPA V, 1993, CANCER RES, V53, P3736
[70]   ELEVATED INSULIN-RECEPTOR CONTENT IN HUMAN BREAST-CANCER [J].
PAPA, V ;
PEZZINO, V ;
COSTANTINO, A ;
BELFIORE, A ;
GIUFFRIDA, D ;
FRITTITTA, L ;
VANNELLI, GB ;
BRAND, R ;
GOLDFINE, ID ;
VIGNERI, R .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (05) :1503-1510